Cargando…
Resistance to Cancer Treatment: The Role of Somatic Genetic Events and the Challenges for Targeted Therapies
Therapeutic resistance remains a major cause of cancer-related deaths. Resistance can occur from the outset of treatment or as an acquired phenomenon after an initial clinical response. Therapeutic resistance is an almost universal phenomenon in the treatment of metastatic cancers. The advent of mol...
Autores principales: | Batist, Gerald, Wu, Jian Hui, Spatz, Alan, Miller, Wilson H., Cocolakis, Eftihia, Rousseau, Caroline, Diaz, Zuanel, Ferrario, Cristiano, Basik, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186943/ https://www.ncbi.nlm.nih.gov/pubmed/22007174 http://dx.doi.org/10.3389/fphar.2011.00059 |
Ejemplares similares
-
Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited
por: Black, Lee, et al.
Publicado: (2013) -
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
por: Nielsen, Torsten H., et al.
Publicado: (2013) -
Systemic cancer therapy: achievements and challenges that lie ahead
por: Palumbo, Michael O., et al.
Publicado: (2013) -
The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
por: Assouline, Sarit, et al.
Publicado: (2012) -
The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome
por: Przybytkowski, Ewa, et al.
Publicado: (2011)